Comprehensive Index of National Vaccine Injury Compensation Program Cases ← all cases Home Firms Attorneys Stats Special Masters About Us

Goldsmith & Hull, APC

Law Firm · Petitioner Practice VICP Petitioner Practice Last verified
Cases filed
7
Comp rate
71%
Total awarded
$1.0M
Tenure
2014–2025
Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
Goldsmith & Hull, APC is a U.S. law firm whose name appears on 7 petitions in the National Vaccine Injury Compensation Program. The firm's filings on file span 2014-2025, with a compensation rate of 71%. Cases on file have produced $1.0M in total awards. The attorneys appearing on this firm's docket include William I. Goldsmith, Jack D. Hull, II.
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Attorneys at this firm (by case volume)
William I. Goldsmith5Jack D. Hull, II4
Most-handled condition categories
Guillain-Barré Syndrome (GBS)4Other / multiple2SIRVA (shoulder injury related to vaccine administration)1

Compensation rate by condition vs program baseline

For each condition this firm has handled at least 3 cases on, comparing the firm's comp rate against the program-wide comp rate for the same condition. Reveals where this firm out- or under-performs the baseline.

Guillain-Barré Syndrome (GBS) -32pt vs program
4 cases at this firm · 2 compensated
This firm
50%
Program
82%

Frequently asked questions about Goldsmith & Hull, APC

Answers built from this firm's public case docket.

How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. Research Goldsmith & Hull, APC's case history below.
How many VICP cases has Goldsmith & Hull, APC filed?
Goldsmith & Hull, APC has filed 7 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2014 and 2025.
What is Goldsmith & Hull, APC's compensation rate?
Goldsmith & Hull, APC's overall compensation rate across 7 VICP cases is 71% (5 compensated).
How much has Goldsmith & Hull, APC won in VICP cases?
Cases filed by Goldsmith & Hull, APC have resulted in $1.0M in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does Goldsmith & Hull, APC handle?
Based on the cases on file, Goldsmith & Hull, APC's practice includes Guillain-Barré Syndrome (GBS), Other / multiple, SIRVA (shoulder injury related to vaccine administration), among other vaccine-related conditions.
FiledFinal judgementPetitionerAttorneyFirm Age at VaccinationVaccineCondition OutcomeSpecial MasterAward
2020-02-272025-09-10Ignacio MontesWilliam I. GoldsmithGoldsmith & Hull, APC54.0yinfluenzaGuillain-Barre syndromedismissedBrian H. Corcoran–
2019-10-292022-07-08David GriswoldWilliam I. GoldsmithGoldsmith & Hull, APC–influenzaGuillain-Barré syndromecompensatedBrian H. Corcoran$50,000
2018-02-222019-10-28RJBWilliam I. GoldsmithGoldsmith & Hull, APC–rotavirusintussusceptioncompensatedBrian H. Corcoran$50,000
2015-12-142019-08-23Tahlia Spector, M.D.Jack D. Hull, II, William I. GoldsmithGoldsmith & Hull; Goldsmith & Hull, APC–influenzashoulder injury related to vaccine administration (SIRVA)compensatedLisa D. Hamilton-Fieldman$812,741
2015-12-102016-10-06B.P.Jack Hull, II, William I. GoldsmithGoldsmith & Hull; Goldsmith & Hull, APC–MMR and meningococcalcellulitiscompensatedNora Beth Dorsey$47,356
2016-01-192016-01-19Frederick J KrugerJack D. Hull, IIGoldsmith & Hull–influenzaGuillain-Barré SyndromedismissedThomas L. Gowen–
2013-08-082014-11-05Gabriela GomezJack D. Hull, IIGoldsmith & Hull, PC–influenzaGuillain-Barré SyndromecompensatedChristian J. Moran$85,000